Short Interest in BIO-key International Inc. (NASDAQ:BKYI) Decreases By 78.5%

Posted by George Bondi on Aug 28th, 2026

BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) saw a large drop in short interest in the month of August. As of August 14th, there was short interest totaling 13,765 shares, a drop of 78.5% from the July 30th total of 63,876 shares. Based on an average trading volume of 111,165 shares, the days-to-cover ratio is currently 0.1 days. Approximately 1.0% of the shares of the company are sold short.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Zacks Research upgraded BIO-key International to a “hold” rating in a research note on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a report on Friday, July 17th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, BIO-key International presently has a consensus rating of “Reduce”.

Check Out Our Latest Stock Report on BIO-key International

BIO-key International Stock Performance

BKYI stock remained flat at $3.10 during trading on Friday. 9,717 shares of the company traded hands, compared to its average volume of 159,001. The stock has a market cap of $4.46 million, a PE ratio of -0.75 and a beta of 0.44. The stock has a 50 day moving average of $4.16 and a 200 day moving average of $5.00. BIO-key International has a 12-month low of $2.88 and a 12-month high of $19.70.

BIO-key International (NASDAQ:BKYI – Get Free Report) last announced its earnings results on Thursday, August 13th. The technology company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.82) by $0.26. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%.The business had revenue of $1.92 million for the quarter, compared to the consensus estimate of $1.80 million. As a group, research analysts forecast that BIO-key International will post -1.62 EPS for the current year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC boosted its stake in shares of BIO-key International Inc. (NASDAQ:BKYI – Free Report) by 49.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the quarter. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. 26.51% of the stock is currently owned by institutional investors and hedge funds.

About BIO-key International

(Get Free Report)

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.